CN101214365B - 一种治疗乳腺增生病的中药组方 - Google Patents
一种治疗乳腺增生病的中药组方 Download PDFInfo
- Publication number
- CN101214365B CN101214365B CN2008100139220A CN200810013922A CN101214365B CN 101214365 B CN101214365 B CN 101214365B CN 2008100139220 A CN2008100139220 A CN 2008100139220A CN 200810013922 A CN200810013922 A CN 200810013922A CN 101214365 B CN101214365 B CN 101214365B
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- chinese medicine
- curcumae
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 claims abstract description 21
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 10
- 238000011282 treatment Methods 0.000 claims description 25
- 241000005787 Cistanche Species 0.000 claims description 7
- 241001250596 Pleione Species 0.000 claims description 6
- 239000010135 fructus aurantii immaturus Substances 0.000 claims description 6
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 4
- 210000004185 liver Anatomy 0.000 abstract description 17
- 230000000694 effects Effects 0.000 abstract description 13
- 210000003734 kidney Anatomy 0.000 abstract description 10
- 230000001276 controlling effect Effects 0.000 abstract description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 4
- 210000005075 mammary gland Anatomy 0.000 abstract description 4
- 230000001717 pathogenic effect Effects 0.000 abstract description 4
- 208000026435 phlegm Diseases 0.000 abstract description 4
- 230000001105 regulatory effect Effects 0.000 abstract description 4
- 238000000034 method Methods 0.000 abstract description 3
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- 230000008569 process Effects 0.000 abstract description 2
- 238000005728 strengthening Methods 0.000 abstract description 2
- 206010020718 hyperplasia Diseases 0.000 abstract 2
- 241000031023 Amana edulis Species 0.000 abstract 1
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241000512259 Ascophyllum nodosum Species 0.000 abstract 1
- 244000003416 Asparagus officinalis Species 0.000 abstract 1
- 235000005340 Asparagus officinalis Nutrition 0.000 abstract 1
- 239000003390 Chinese drug Substances 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 241000737241 Cocos Species 0.000 abstract 1
- 241000234276 Curculigo Species 0.000 abstract 1
- 241000234653 Cyperus Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 241000329195 Sparganium erectum Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 9
- 210000000481 breast Anatomy 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000035475 disorder Diseases 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000003172 expectorant agent Substances 0.000 description 5
- 230000003419 expectorant effect Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 230000004087 circulation Effects 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000002110 toxicologic effect Effects 0.000 description 3
- 231100000027 toxicology Toxicity 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 208000035619 Back crushing Diseases 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000000571 Fibrocystic breast disease Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 208000011803 breast fibrocystic disease Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 231100000682 maximum tolerated dose Toxicity 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种治疗乳腺增生病的中药组方,由以下重量比的中药原料配制而成:天门冬6-15g,柴胡6-15g,白芍6-30g,鹿角霜6-15g,巴戟天10-20g,仙茅6-15g,当归6-20g,蒲公英10-50g,肉苁蓉10-25g,三棱6-15g,莪术6-15g,半枝莲5-20g,山慈菇3-10g,香附6-15g,枳实6-15g,青皮6-15g,郁金6-15g,昆布10-30g,茯苓6-20g。以“疏肝解郁,化瘀消痰,软坚散结,调摄冲任,补益肝肾,扶正祛邪”治疗乳腺增生病,该中药组方配伍合理,无毒副作用,加工方便,成本低廉,治疗效果明显。
Description
技术领域
本发明涉及一种治疗乳腺增生病的中药组合物,属于中医领域。
背景技术
乳腺增生是妇女常见、多发病之一,它是乳腺组织的良性增生。多见于25-45岁女性。36%左右的育龄期妇女有不同程度的乳腺增生。其本质上是一种生理增生与复旧不全造成的乳腺正常结构的紊乱。它既不是肿瘤,也不是炎症。故称“乳腺增生病”。世界卫生组织(WHO)统称“良性乳腺结构不良”。
激素类药物治疗乳腺增生病,虽然近期效果好,可明显缓解症状,但长期应用可干扰人体激素间的平衡,复发率高,且有不同程度的副作用,不宜作为常规用药。祖国医学对本病的论治进行了诸多的探讨,积累了大量行之有效的理法方药,对乳腺增生病具有明显抗突变抗促癌作用。有些中药以“软坚散结、活血消痛、清热解毒”治疗乳腺增生病,有时存在配伍不合理、疗效不显著、治疗时间长、复发率较高的缺点。
发明内容
本发明的目的是提供一种效果显著、无毒副作用,用药方便,成本低廉的治疗乳腺增生病的中药组方,为实现以上目的,本发明所采取的技术方案为:
该中药组方由以下重量比的中药原料配制而成:天门冬6-15g,柴胡6-15g,白芍6-30g,鹿角霜6-15g,巴戟天10-20g,仙茅6-15g,当归6-20g,蒲公英10-50g,肉苁蓉10-25g,三棱6-15g,莪术6-15g,半枝莲5-20g,山慈菇3-10g,香附6-15g,枳实6-15g,青皮6-15g,郁金6-15g,昆布10-30g,茯苓6-20g。
各中药原料的最佳重量比为:天门冬12g,柴胡9g,白芍9g,鹿角霜9g,巴戟天9g,仙茅9g,当归9g,蒲公英12g,肉苁蓉9g,三棱9g,莪术9g,半枝莲9g,山慈菇5g,香附9g,枳实9g,青皮9g,郁金9g,昆布15g,茯苓9g。
柴胡:归心包经、肝、三焦经:有升举阳气,能条达肝气而疏肝解郁。香附、青皮归肝、胃经:有疏肝理气、散结消滞、香附为妇科主药,尤适用于肝气郁结而致的月经不调,乳房胀痛结块等症。祖国医学记载有人从心论治乳病的学说,心主神志,肝主疏泄,都与精神情志活动有关。当归、白芍归肝、脾经:补血养血、柔肝止痛、平抑肝阳,二者为妇科调经要药。鹿角霜归肝、肾经,补肝肾,益精血适用于肾阳不足。仙茅、巴戟天、肉苁蓉归肝、肾经,大肠经:补肾助阳,肉苁蓉《本草汇言》曰:养命门、滋肾气、补精血之要药也。男子丹元虚冷而阳道久沉,妇女冲任失调而阴气不治、此乃平补之剂,温而不热,补而不峻、暖而不燥滑而不泄,故有从容之名。天门冬、归肺肾经:清肺降火、滋阴润燥,有报告治疗乳房胀痛效佳。郁金归心肝、胆经,活血止痛,行气解郁,凉血清心《本草备要》曰“行气解郁,泄血破瘀。凉血热,散肝郁。”治疗妇人血脉逆行之要药。莪术、三棱、归肝、脾经:破血祛瘀,行气止痛《本草纲目》曰“三棱能破气散结,故能治诸病。”枳实归脾、胃经:破气消积、化瘀祛痞。《别录》曰“除胸肋痰癖,遂停水,破结实,消胀满心下急痞痛,逆气肋风痛,安胃气。”昆布归肝、肾、胃经:消痹软坚、利水。茯苓归心脾,肾经,利水渗湿,健脾安神。茯苓为治痰主药。痰之本水也,茯苓可以行水;痰之动,湿也,茯苓可以行湿。公英、半枝莲、山茨菇归肝、胃经:清热解毒、消痈散结利湿,诸药有抗癌作用,为治疗癌症的要药用小的剂量预防癌变有一定的作用。蒲公英亦有疏通乳管的功能。以上诸药的配伍,对治疗乳腺增生将起到很好的作用。
本发明针对乳腺增生病的病因“情志内伤,肝气不舒,肾气不足,冲任失调,痰瘀凝结”,以“疏肝解郁,化瘀消痰,软坚散结,调摄冲任,补益肝肾,扶正祛邪”治疗乳腺增生病,该中药组方配伍合理,无毒副作用,加工方便,成本低廉,治疗效果明显,经临床1200病例的观察,治愈率65%,总有效率97%以上。
具体实施方式
下面结合实施例对本发明做进一步说明:
首先称重以下各中药原料:天门冬12g,柴胡9g,白芍9g,鹿角霜9g,巴戟天9g,仙茅9g,当归9g,蒲公英12g,肉苁蓉9g,三棱9g,莪术9g,半枝莲9g,山慈菇5g,香附9g,枳实9g,青皮9g,郁金9g,昆布15g,茯苓9g;然后混合后粉碎过筛,泛制水丸后干燥;最后整粒分栏后包装既得成品。
也可以采用常规的中药制备方法做成胶囊、滴丸、汤剂等。
下面对按照本发明的组方制取的舒奇丸进行毒理学实验和临床实验说明:
1、毒理学实验:
舒奇丸经毒理学实验、慢性毒性实验连续用药60天,给药量是临床用药量的6.5倍,实验动物无明显中毒症状,无明显肝肾功能损害;LD50无小鼠死亡;最大耐受量超过人体用药量的500倍;急性致死量大于人体用药量的950倍。
2、临床对比实验:
1)分组情况:将符合诊断标准的260例患者随机分成治疗组和对照组,即舒奇丸治疗组和乳癖消、维生素E对照组,其中治疗组190例,对照组70例。
2)治疗给药方法及疗程
治疗组:口服舒奇丸9g,每日3次。对照组:口服乳癖消6片维生素E2粒,每日3次。两组均以3个疗程,即结束观察,服药方法分别为月经干净后第6日、第10日、第15日开始服药,分别服药为第一疗程20天、第二疗程15天、第三疗程10天,共3个疗程后统计疗效。
3)疗效标准及疗效结果:
临床疗效标准根据中国中医药管理局1994发布的《中医病证诊断疗效标准》执行。(治愈:乳房肿块及疼痛消失;好转:乳房肿块缩小疼痛减轻或消失;未愈:乳房肿块及疼痛无变化。)
经过3个疗程治疗分析观察到的疗效结果总结如下:
表1两组疗效比较
统计学处理:X2=19.71 P=0.0002,P<0.001,具有显著性差别。
表2两组分型治疗效果的比较
从两组治疗观察:治疗组无论在冲任失调型,肝郁痰凝型及混合型治疗效果均很满意。对照组对冲任失调型的治疗效果,不如肝郁痰凝型,止痛效果满意,调摄内分泌的作用较差。
Claims (2)
1.一种治疗乳腺增生病的中药组合物,其特征在于由以下重量比的中药原料配制而成:天门冬6-15g,柴胡6-15g,白芍6-30g,鹿角霜6-15g,巴戟天10-20g,仙茅6-15g,当归6-20g,蒲公英10-50g,肉苁蓉10-25g,三棱6-15g,莪术6-15g,半枝莲5-20g,山慈菇3-10g,香附6-15g,枳实6-15g,青皮6-15g,郁金6-15g,昆布10-30g,茯苓6-20g。
2.根据权利要求1所述的一种治疗乳腺增生病的中药组合物,其特征在于各中药原料的最佳重量比为:天门冬12g,柴胡9g,白芍9g,鹿角霜9g,巴戟天9g,仙茅9g,当归9g,蒲公英12g,肉苁蓉9g,三棱9g,莪术9g,半枝莲9g,山慈菇5g,香附9g,枳实9g,青皮9g,郁金9g,昆布15g,茯苓9g。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100139220A CN101214365B (zh) | 2008-01-14 | 2008-01-14 | 一种治疗乳腺增生病的中药组方 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100139220A CN101214365B (zh) | 2008-01-14 | 2008-01-14 | 一种治疗乳腺增生病的中药组方 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101214365A CN101214365A (zh) | 2008-07-09 |
CN101214365B true CN101214365B (zh) | 2010-06-09 |
Family
ID=39620914
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008100139220A Expired - Fee Related CN101214365B (zh) | 2008-01-14 | 2008-01-14 | 一种治疗乳腺增生病的中药组方 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101214365B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101401914B (zh) * | 2008-11-07 | 2011-01-12 | 刘秋兰 | 一种治疗乳腺增生的药物 |
CN104189719A (zh) * | 2013-08-03 | 2014-12-10 | 李占令 | 一种治疗乳腺增生的中药配伍及方法 |
CN103446546B (zh) * | 2013-09-18 | 2014-12-10 | 司继爱 | 消癥散结胶囊及其制备方法 |
CN103961488A (zh) * | 2014-05-08 | 2014-08-06 | 徐爱霞 | 一种治疗冲任失调型乳腺增生的中药制剂 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1857678A (zh) * | 2006-04-05 | 2006-11-08 | 山东中医药大学附属医院 | 一种治疗乳腺增生病的药物及其制备方法 |
-
2008
- 2008-01-14 CN CN2008100139220A patent/CN101214365B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1857678A (zh) * | 2006-04-05 | 2006-11-08 | 山东中医药大学附属医院 | 一种治疗乳腺增生病的药物及其制备方法 |
Non-Patent Citations (3)
Title |
---|
刘英英.柴芩乳康颗粒制剂工艺、质量标准、稳定性及初步肠吸收研究.中国优秀硕士学位论文全文数据库.2005,4-22. * |
黄海锋,等.乳腺增生病中医治疗近况.湖南中医学院学报16 3.1996,16(3),72-74. |
黄海锋,等.乳腺增生病中医治疗近况.湖南中医学院学报16 3.1996,16(3),72-74. * |
Also Published As
Publication number | Publication date |
---|---|
CN101214365A (zh) | 2008-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101167847B (zh) | 一种有效治疗皮肤病的中药白酒制剂 | |
CN1375298A (zh) | 三七复方止痛合剂 | |
CN103463528A (zh) | 一种治疗慢性湿疹的中药组合物 | |
CN102228485B (zh) | 用于烧伤康复的组合物及其制备方法 | |
CN100358571C (zh) | 治疗乳腺疾病的热敷药贴和药膏贴及其制备方法 | |
CN102861287B (zh) | 一种治疗湿热下注淤血型糖尿病足的中药组合物及其制备方法 | |
CN102631413A (zh) | 一种治疗痤疮的中药组合物 | |
CN103386022A (zh) | 一种治疗结核性胸膜炎的中药组合物 | |
CN101214365B (zh) | 一种治疗乳腺增生病的中药组方 | |
CN104984316A (zh) | 用于治疗女性宫寒的药物 | |
CN102526592B (zh) | 用于防治心脑血管病和免疫力低下等多种疾病的中药组合物 | |
CN1824009B (zh) | 一种可内外服用的多用途药物组合物 | |
CN102614424A (zh) | 一种用于治疗水肿的中药 | |
CN102727738B (zh) | 用于治疗慢性阻塞性肺疾病的中药组合物及其制备方法 | |
CN1298382C (zh) | 一种治疗胆囊炎的中药制剂及其制备方法 | |
CN100411666C (zh) | 用于治疗蛇伤、及蜂、蜈蚣、毒虫咬伤和痈、疽、疖的药物组合物 | |
CN1883642A (zh) | 一种用于治疗乳腺增生病的药物 | |
CN102861292B (zh) | 一种治疗食管癌的药物及其制备方法 | |
CN101085303A (zh) | 一种内服治疗乳腺增生的中药组合物 | |
CN1410093A (zh) | 一种治疗囊肿的药物 | |
CN101032575A (zh) | 一种治疗心脑血管疾病的中药 | |
CN104001100A (zh) | 一种治疗picc静脉血栓的中药组合物及其制备方法 | |
CN1286500C (zh) | 治疗关节疼痛的药物 | |
CN104117018A (zh) | 一种治疗冠心病的中药组合物 | |
CN103212013A (zh) | 一种治疗胃脘痛的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100609 Termination date: 20130114 |
|
CF01 | Termination of patent right due to non-payment of annual fee |